Glycoproteogenomics characterizes the CD44 splicing code driving bladder cancer invasion
c. gaiteiro, J. Soares, M. Relvas Santos, A. Peixoto, D. Ferreira, A. Brandao, E. Fernandes, R. Azevedo, P. Paulo, C. Palmeira, L. Lima, R. Freitas, A. Miranda, H. Osorio, A. M. Silva, , J. A. Ferreira
This study identifies CD44s as a biomarker of poor prognosis in bladder cancer and demonstrates the utility of glycoproteogenomics for characterizing splicing and glycosylation patterns linked to cancer invasion.
bioRxiv · Sep 4, 2021 · PreprintCancer Biology